Top Markets
#1 Islamic Coin Islamic Coin +152.31%
#2 Bitway Bitway +45.94%
#3 Starpower Starpower +39.28%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +32.39%
#5 aelf aelf +26.47%
#6 Pons Pons +26.20%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.27%
#8 SkyAI SkyAI +18.19%
#9 Decred Decred +16.18%
#10 Ocean Protocol Ocean Protocol +15.29%
Coin of the day
Islamic Coin Islamic Coin
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Medivir AB (publ) Medivir AB (publ)

Medivir AB (publ)

MVIR-B
Rang în acțiuni #29651
Medivir AB (publ) is a pharmaceutical company established in 1987 and... Medivir AB (publ) is a pharmaceutical company established in 1987 and headquartered in Huddinge, Sweden. It is dedicated to the research, development, and global commercialization of medicines, with a primary focus on oncology. The company currently markets Zoviduo (formerly Xerclear) for the treatment of labial herpes. Its robust development pipeline includes Remetinostat, targeting MF cutaneous T-cell lymphoma and basal cell carcinoma; MIV-818, aimed at liver cancer; and MIV-711, being advanced for osteoarthritis. Additionally, Medivir is progressing Birinapant and IGM-8444 for various solid tumor indications. Collaborative efforts are also key to its strategy, including a research partnership with SciLifeLab's Drug Discovery and Development Platform to discover antivirals for SARS CoV-2, alongside licensing agreements with Tango Therapeutics for a preclinical research program and with Ubiquigent Limited for the USP7 preclinical research program.
Preț acțiune
$0.68377137
Ultima sincronizare: 2023-05-23
Capitalizare de piață
$20.23M
Schimbare (1 zi)
-0.60%
Schimbare (1 an)
0.00%
Țară
SE
Tranzacționează Medivir AB (publ) (MVIR-B)

Categorie

Healthcare
Venituri pentru Medivir AB (publ) (MVIR-B)
Venituri în Aug 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale Medivir AB (publ), venitul actual al companiei (TTM) este 0. În anul 2026, compania a avut un venit de 0 egal cu venitul din anul 2026, care a fost de 0. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Medivir AB (publ) din 2026 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
Nu sunt suficiente date pentru perioada selectată.
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR